CSIMarket
 


Cardiovascular Systems Inc   (CSII)
Other Ticker:  
 

Cumulative Cardiovascular Systems Inc 's Leverage Ratio for Trailing Twelve Months Period

CSII's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

CSII Leverage Ratio for Trailing Twelve Months Period

(Dec 31 2022)
II. Quarter
(Sep 30 2022)
I. Quarter
(Jun 30 2022)
IV. Quarter
(Mar 31 2022)
III. Quarter
(Dec 31 2021)
II. Quarter
Y / Y Equity Growth -7.76 % -7.99 % -7.93 % -6.27 % -5.22 %
Y / Y Total Liabilities Growth 12.02 % 2.32 % -13.3 % -10.23 % -14.65 %
Leverage Ratio for Trailing Twelve Months Period 0.21 0.2 0.19 0.2 0.2
Total Ranking # 820 # 791 # 799 # 827 # 821
Seq. Equity Growth -1.14 % -2.94 % -1.59 % -2.32 % -1.39 %
Seq. Total Liabilities Growth 4.68 % -6.09 % 5.57 % 7.95 % -4.39 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2022
On the trailing twelve months basis Due to net new borrowings of 4.68%, Leverage Ratio for Trailing Twelve Months Period improved to 0.21, below Cardiovascular Systems Inc 's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Medical Equipment & Supplies industry 42 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Cardiovascular Systems Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are CSII's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 43
Sector # 320
S&P 500 # 611


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.6 0.38 0.19
(Dec 31 2017)   (Sep. 30, 2014)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2022, within Medical Equipment & Supplies Industry Leverage Ratio for Trailing Twelve Months Period
Envista Holdings Corporation  0.57 
Innovage Holding Corp   0.56 
Bausch and Lomb Corp  0.56 
Vivos Therapeutics Inc   0.56 
Biosig Technologies Inc   0.55 
Cytosorbents Corporation  0.55 
Transmedics Group Inc   0.55 
Conformis inc   0.54 
Helius Medical Technologies inc   0.52 
Vicarious Surgical Inc   0.51 
Rxsight Inc   0.51 
Merit Medical Systems Inc  0.51 
Genedx Holdings Corp   0.50 
Soleno Therapeutics Inc  0.49 
Enovis Corporation  0.48 
Catheter Precision Inc   0.48 
Alcon inc   0.48 
Nephros Inc   0.47 
Si bone inc   0.45 
Warby Parker Inc   0.45 
Marizyme Inc   0.44 
Paragon 28 Inc   0.44 
Edap Tms Sa  0.44 
Surmodics Inc  0.44 
Lyra Therapeutics Inc   0.43 
Edwards Lifesciences Corporation  0.43 
Alpha Tau Medical Ltd   0.43 
Antares Pharma Inc   0.42 
Nuo Therapeutics Inc   0.42 
Privia Health Group Inc   0.41 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com